The Impact of Omicron-related Stress on Mental Health in the General Population of China
- PMID: 40356002
- PMCID: PMC12069919
- DOI: 10.62641/aep.v53i3.1831
The Impact of Omicron-related Stress on Mental Health in the General Population of China
Abstract
Background: Outbreaks of infectious disease represent unique stressors for the general population. In this study, we investigated the prevalence of mental health symptoms and associated risk factors in the general population of China during the Omicron wave.
Methods: We conducted a cross-sectional and large sample online survey during the surge of Omicron cases between 17 December 2022 and 8 January 2023 among Chinese citizens. Then we assessed the prevalence of symptoms of anxiety, depression, insomnia, acute stress disorder, and resilience levels, in the general population of China during the Omicron pandemic by utilizing the coronavirus disease 2019 (COVID-19) anxiety scale (CAS), the Center for Epidemiologic Studies Depression Scale (CES-D), the Insomnia Severity Index scale (ISI), the Stanford Acute Stress Reaction Questionnaire (SASRQ), and the Connor-Davidson Resilience Scale (CD-RISC). Multivariate logistic regression analyses were used to identify demographic and Omicron-related risk factors.
Results: In total, 2800 respondents across 32 provinces and autonomous regions on the Chinese mainland participated in this survey; 1133 (40.5%) were male, and 1860 (66.4%) were 40 years-of-age or younger. The prevalence of anxiety, depression, insomnia, and acute stress disorder was 52%, 58.3%, 45.2%, and 34.8%, respectively. After adjustment for covariates, female gender, a younger age, being unmarried, low income, and a non-medical post were all associated with mental health problems. During the course of infection, participants had a higher risk of developing symptoms of anxiety (odds ratio [OR]: 1.27; 95% confidence interval [CI]: 1.03-1.57; p = 0.028), depression (OR: 1.76; 95% CI: 1.44-2.16; p < 0.001), insomnia (OR: 1.95; 95% CI: 1.57-2.42, p < 0.001) and acute stress disorder (OR: 1.56; 95% CI: 1.25-1.93, p = 0.001). In addition, we found that a lower resilience among participants was associated with a higher risk of anxiety, depression, insomnia, and acute stress disorder (p < 0.001).
Conclusion: Omicron-related stress had a profound effect on the mental health of the general population of China, especially among those infected during the course of coronavirus disease 2019 (COVID-19) and with lower resilience. Our findings suggest that mental health can be improved during a pandemic by increasing resilience.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.JAMA Netw Open. 2020 Jul 1;3(7):e2014053. doi: 10.1001/jamanetworkopen.2020.14053. JAMA Netw Open. 2020. PMID: 32609353 Free PMC article.
-
Mental health during the omicron pandemic: A comparison between medical staff and non-medical staff.J Affect Disord. 2023 Nov 1;340:221-227. doi: 10.1016/j.jad.2023.08.005. Epub 2023 Aug 2. J Affect Disord. 2023. PMID: 37541598
-
Mental Health in Frontline Medical Workers during the 2019 Novel Coronavirus Disease Epidemic in China: A Comparison with the General Population.Int J Environ Res Public Health. 2020 Sep 9;17(18):6550. doi: 10.3390/ijerph17186550. Int J Environ Res Public Health. 2020. PMID: 32916836 Free PMC article.
-
Prevalence and associated factors of depressive and anxiety symptoms among healthcare workers in the post-pandemic era of COVID-19 at a tertiary hospital in Shenzhen, China: A cross-sectional study.Front Public Health. 2023 Mar 20;11:1094776. doi: 10.3389/fpubh.2023.1094776. eCollection 2023. Front Public Health. 2023. PMID: 37020820 Free PMC article.
-
A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action.Mol Psychiatry. 2022 Aug;27(8):3214-3222. doi: 10.1038/s41380-022-01638-z. Epub 2022 Jun 6. Mol Psychiatry. 2022. PMID: 35668158 Free PMC article.
References
-
- Meo SA, Meo AS, Al-Jassir FF, Klonoff DC. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. European Review for Medical and Pharmacological Sciences . 2021;25:8012–8018. - PubMed